000			02863cam a2200349 a 4500
003			EG-GiCUC
005			20250223031348.0
008			151205s2015 ua h f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.11.01.Ph.D.2015.An.C
100	0		_aAntony Adel Fahmy
245	1	0	_aComparative study of intrathecal dexmedetomidine with intrathecal midazolam used as adjuvants to bupivacaine in orthopedic surgeries / _cAntony Adel Fahmy ; Supervised Mohamed Kamal Aboulghate , Shereen Moustafa Amin , Ahmed Ragab Abdelhakim
246	1	5	_aدراسة لمقارنة حقن عقار الديكسميداتوميدين بعقار الميدازولام تحت الأم الجافية فى التخدير النصفى كعوامل مساعدة للبيوبيفاكيين فى عمليات العظام
260			_aCairo : _bAntony Adel Fahmy , _c2015
300			_a78 P. : _bfacsimiles ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Anaesthesia
520			_aSpinal anesthesia is a very common technique used in orthopedic surgeries involving hip and lower limbs. It provides adequate analgesia both intra and post - operative and it also avoids complications associated with general anesthesia. Spinal block remains the first choice in these kinds of surgeries due to its rapid onset, superior blockade, low risk of infection as from catheter in situ in cases of epidural, less failure rates and cost effectiveness, but has the draw backs of shorter duration of block and lack of postoperative analgesia. Use of intrathecal adjuvants has gained popularity with the aim of prolonging the duration of block, better success rate and patient satis faction. 90 patients, ASA I / II were enrolled into the study. All patients had spinal anesthesia and randomly allocated into one of three groups. Group C: (30 patients): The patient received 15 mg of bupivacaine 0.5% plus 0.4 ml saline, Group M: (30 patients): The patient received 15 mg of bupivacaine 0.5% plus 0.4 ml of midazolam (2mg), Group D: (30 patients): The patient received 15 mg of bupivacaine 0.5% plus 0.1 ml dexmedetomidine (10 æg) plus 0.3 ml saline. In all groups assessment was done for time to reach T10 dermatome, time to peak sensory level, time to reach complete motor block (bromage 3), regression to S1 dermatome and time for motor recovery
530			_aIssued also as CD
653		4	_aAdjuvants
653		4	_aBupivacaine
653		4	_aSpinal anesthesia
700	0		_aAhmed Ragab Abdelhakim , _eSupervisor
700	0		_aMohamed Kamal Aboulghate , _eSupervisor
700	0		_aShereen Moustafa Amin , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c53743 _d53743